Proteinase dysbalance in pathology: The neprilysin (NEP) and angiotensin-converting enzyme (ACE) families

Cellular and Molecular Biology

Volumn 52, Issue 4, 2006, Pages 40-48

  Turner, A J ^a   Nalivaeva, N N ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NONE

Author keywords

Alzheimer's disease (AD); Amyloid; Angiotensin converting enzyme (ACE); Cancer; Cardiovascular diseases; Endothelin converting enzyme (ECE 1); Metalloproteinase; Neprilysin (NEP); Proteolysis; Zinc peptidase

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; PROTEINASE;

ALZHEIMER DISEASE; CARDIOVASCULAR SYSTEM; CONFERENCE PAPER; GENE SEQUENCE; HUMAN; HYPERTENSION; NERVE DEGENERATION; NONHUMAN; SARS CORONAVIRUS;

AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; NEPRILYSIN; PEPTIDE HYDROLASES; RENIN; SUBSTRATE SPECIFICITY;

SARS CORONAVIRUS;

EID: 34247563485     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T725     Document Type: Conference Paper

References (88)

1. Allinson, T., Parkin, E., Turner, A.J. and Hooper, N.M. The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein. Eur. J. Biochem. 2004. 271: 2539-2547.
2. Apelt, J., Ach, K. and Schliebs, R. Aging-related downregulation of neprilysin, a putative β-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaques. Neurosci. Lett. 2003. 339: 183-186.
3. Arndt, J.W., Hao, B., Ramakrishnan, V., Cheng, T., Chan, S.I. and Chan, M.K. Crystal structure of a novel carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus. Structure. 2002. 10: 215-224.
4. Bralet, J. and Schwartz, J.-C. Vasopeptidase inhibitors: an emerging class of cardiovascular drugs. Trends Pharmacol. Sci. 2001. 22: 106-109.
5. Broccolini, A., Gidaro, T., Morosetti, R., Gliubizzi, C., Servidei, T., Pescatori, M., Tonali, P.A., Ricci, E. and Mirabella, M. Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. J. Neurochem. 2006. 96: 777-789.
6. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C. and Glabe, C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 1992. 267: 546-554.
7. Cao, X. and Sudhof, T.C. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science. 2001. 293: 115-120.
8. Carpentier, M., Robitaille, Y., DesGroseillers, L., Boileau, G. and Marcinkiewicz, M. Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 2002. 61: 849-856.
9. Carson, J.A. and Turner, A.J. β-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J. Neurochem. 2002. 81: 1-8.
10. Chen, F., Hasegawa, H., Schmitt-Ulms, G., Kawarai, T., Bohm, C., Katayama, T., Gu, Y, Sanjo, N., Glista, M., Rogaeva, E., Wakutani, Y., Pardossi-Piquard, R., Ruan, X., Tandon, A., Checler, F., Marambaud, P., Hansen, K., Westaway, D., St George-Hyslop, P. and Fraser, P. TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature. 2006. 440: 1208-1212.
11. Cordy, J.M., Hooper, N.M., Turner, A.J. The involvement of lipid rafts in Alzheimer's disease. Mol. Membr. Biol. 2006. 23: 111-122.
12. Crackower, M.A., Sarao, R., Oudit, G.Y., Yagil, C., Kozieradzki, I., Scanga, S.E., Oliveira-dos-Santos, A.J., da Costa, J., Zhang, L., Pei, Y., Scholey, J., Ferrario, C.M., Manoukian, A.S., Chappell, M.C., Backx, P.H., Yagil, Y. and Penninger, J.M. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002. 417: 799-802.
13. Dales, N.A., Gould, A.E., Brown, J.A., Calderwood, E.F., Guan, B., Minor, C.A., Gavin, J.M., Hales, P., Kaushik, V.K., Stewart, M., Tummino, P.J., Vickers, C.S., Ocain, T.D. and Patane, M.A. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc. 2002. 124: 11852-11853.
14. Dawson, L.A., Maitland, N.J., Turner, A.J., Usmani, B.A. Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression. Br. J. Cancer. 2004. 90: 1577-1582.
15. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., Breitbart, R.E. and Acton, S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000. 87: 1-9.
16. Eckman, E.A., Reed, D.K. and Eckman, C.B. Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme. J. Biol. Chem. 2001. 276: 24540-24548.
17. Eckman, E.A., Watson, M., Marlow, L., Sambamurti, K. and Eckman, C.B. Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J. Biol. Chem. 2003. 278: 2081-2084.
18. Facchinetti, P., Rose, C., Schwartz, J.C., Ouimet, T. Ontogeny, regional and cellular distribution of the novel metalloprotease neprilysin 2 in the rat: a comparison with neprilysin and endothelinconverting enzyme-1. Neuroscience. 2003. 118: 627-639.
19. Fisk, L., Nalivaeva, N.N. and Turner, A.J. Regulation of endothelin-converting enzyme-1 expression in human neuroblastoma cells. Exp. Biol. Med. 2006. 231:1048-53.
20. st Lorne Proteins Conference. 2006. P. 88.
21. Francis, R., McGrath, G., Zhang, J., Ruddy, D.A., Sym, M., Apfeld, J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M.C., Parks, A.L., Xu, W., Li, J., Gurney, M., Myers, R.L., Himes, C.S., Hiebsch, R., Ruble, C., Nye, J.S., Curtis, D. Aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell. 2002. 3: 85-97.
22. Guy, J.L., Jackson, R.M., Acharya, K.R., Sturrock, E.D., Hooper, N.M. and Turner, A.J. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry. 2003. 42: 13185-13192.
23. Guy, J.L., Jackson, R.M., Jensen, H.A., Hooper, N.M. and Turner, A.J. Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J. 2005. 272: 3512-3520.
24. Hardy, J.A. and Higgins, G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992. 256: 184-185.
25. Hass, M.R. and Yankner, B.A. A γ-secretase-independent mechanism of signal transduction by the amyloid precursor protein. J. Biol. Chem. 2005. 280: 36895-36904.
26. Hebert, S.S., Serneels, L., Tolia, A., Craessaerts, K., Derks, C., Filippov, M.A., Muller, U. and De Strooper, B. Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep. 2006. May 19; [Epub ahead of print]
27. Hersh, L.B., Yu, J., Zhu, H., Gao, J.T., Mucke, L. and Kindy, M.S. J. Neurochem. 2002. 81 (Suppl. 1): 67.
28. Ho, T.Y., Wu, S.L., Chen, J.C., Li, C.C., Hsiang, C.Y. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2006. [Epub ahead of print], PMID: 16730806.
29. Hooper, N.M. and Turner, A.J. An ACE structure. Nature Struct. Biol. 2003. 10: 155-157.
30. Hooper, N.M., Karran, E.H. and Turner, A.J. Membrane protein secretases. Biochem. J. 1997. 321: 265-279.
31. Hooper, N.M., Keen, J., Pappin, D.J.C. and Turner, A.J. Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane. Biochem. J. 1987. 247: 85-93.
32. Howell, S., Caswell, A.M., Kenny, A.J. and Turner, A.J. Membrane peptidases on human osteoblast-like cells in culture: hydrolysis of calcitonin and hormonal regulation of endopeptidase-24.11. Biochem. J. 1993. 290: 159-164.
33. Huang, L., Sexton, D.J., Skogerson, K., Devlin, M., Smith, R., Sanyal, I., Parry, T., Kent, R., Enright, J., Wu, Q.-L., Conley, G., DeOliveira, D., Morganelli, L., Ducar, M., Wescott, C.R. and Ladner, R.C. Novel peptide inhibitors of angiotensin-converting enzyme 2. J. Biol. Chem. 2003. 278:15532-15540.
34. Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., Crackower, M.A., Fukamizu, A., Hui, C.C., Hein, L., Uhlig, S., Slutsky, A.S. Jiang, C. and Penninger, J.M. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005. 436: 112-116.
35. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Seikiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H-J., Hama, E., Sekine-Aizawa, Y. and Saido, T.C. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 2000. 6: 143-150.
36. Jellinger, K.A. and Attems, J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J. Neurol. Sci. 2005. 229-230: 37-41.
37. Kenny, A.J. and Stephenson, S.L. Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide. FEBS Lett. 1988. 232: 1-8.
38. Kim, H.M., Shin, D.R., Yoo, O.J., Lee, H. and Lee, J.-O. Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril. FEBS Lett. 2003. 538: 65-70.
39. Kumar, G.K., Runold, M., Ghai, R.D., Cherniack, N.S., Prabhakar, N.R. Occurrence of neutral endopeptidase activity in the cat carotid body and its significance in chemoreception. Brain Res. 1990. 517: 341-343.
40. Kumar, G.K., Yu, R.K., Overholt, J.L. and Prabhakar, N.R. Role of substance P in neutral endopeptidase modulation of hypoxic response of the carotid body. Adv. Exp. Med. Biol. 2000. 475: 705-713.
41. Lambert, D.W., Yarski, M., Warner, F.J., Thornhill, P., Parkin, E.T., Smith, A.I., Hooper, N.M. and Turner AJ. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin converting enzyme-2 (ACE2). J. Biol. Chem. 2005. 280: 30113-30119.
42. Letarte, M., Vera, S., Tran, R., Addis, J.B., Onizuka, R.J., Quackenbush, E.J., Jongeneel, C.V. and McInnes, R.R. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J.. Exp. Med. 1988. 168: 1247-1253.
43. Li, F., Li, W., Farzan, M. and Harrison, S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005. 309: 1864-1868.
44. Li, W., Moore, M.J., Vasilieva, N., Sui, J., Wong, S.K., Berne, M.A., Somasundaran, M., Sullivan, J.L., Luzuriaga, K., Greenough, T.C., Choe, H. and Farzan, M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003. 426: 450-454.
45. Lilius, L., Forsell, C., Axelman, K., Winblad, B., Graff, C. and Tjernberg, L. No association between polymorphisms in the neprilysin promoter region and Swedish Alzheimer's disease patients. Neurosci. Lett. 2003. 337, 111-113.
46. Malfroy, B., Swerts, J.P., Guyon, A., Roques, B.P. and Schwartz, J.-C. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature. 1978. 276: 523-526.
47. Marr, R.A., Rockenstein, E., Mukherjee, A., Kindy, M.S., Hersh, L.B., Gage, F.H., Verma, I.M., Masliah, E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 2003. 23: 1992-1996.
48. Matsas, R., Fulcher, I.S., Kenny, A.J. and Turner, A.J. Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc. Natl. Acad. Sci. U.S.A. 1983. 80: 3111-3115.
49. Matsas, R., Turner, A.J. and Kenny, A.J. The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. Biochem. J. 1984. 223: 433-440.
50. Mohajeri, M.H., Wollmer, M.A. and Nitsch, R.M. Aβ42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo. J. Biol. Chem. 2002. 277: 35460-35465.
51. Nalivaeva, N.N., Fisk, L., Kochkina, E.G., Plesneva, S.A., Zhuravin, I.A., Babusikova, E., Dobrota, D., Turner, A.J. Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann. N. Y. Acad. Sci. 2004. 1035: 21-33.
52. Natesh, R., Schwager, S.L.U., Sturrock, E.D. and Acharya, K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature. 2003. 421: 551-554.
53. Neve, R.L. A new wrestler in the battle between alpha- and beta-secretases for cleavage of APP. Trends Neurosci. 2003. 26: 461-463.
54. Oefner, C., D'Arcy, A., Nennig, M., Winkler, F.K. and Dale, G.E. Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon. J. Mol. Biol. 2000. 296: 341-349.
55. Papandreou, C.N., Usmani, B., Geng, Y., Bogenrieder, T., Freeman, R., Wilk, S., Finstad, C.L., Reuter, V.E., Powell, C.T., Scheinberg, D., Magill, C., Scher, H.I., Albino, A.P. and Nanus, D.M. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat. Med. 1998. 4: 50-57.
56. Pardossi-Piquard, R., Dunys, J., Yu, G., St George-Hyslop, P., Alves da Costa, C. and Checler, F. Neprilysin activity and expression are controlled by nicastrin. J. Neurochem. 2006. 97:1052-1056.
57. Pardossi-Piquard, R., Petit, A., Kawarai, T., Sunyach, C., Alves da Costa, C., Vincent, B., Ring, S., D'Adamio, L., Shen, J., Muller, U., St George Hyslop, P.and Checler, F. Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron. 2005. 46: 541-554.
58. Passer, B., Pellegrini, L., Russo, C., Siegel, R.M., Lenardo, M.J., Schettini, G., Bachmann, M., Tabaton, M. and D'Adamio, L. Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J. Alzheimers Dis. 2000. 2: 289-301.
59. Puente, X.S., Sanchez, L.M., Overall, C.M. and Lopez-Otin, C. Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 2003. 4: 544-558.
60. Quaschning, T. Vasopeptidase inhibition for blood pressure control: emerging experience. Curr. Pharm. Des. 2005. 11: 3293-3299.
61. Rawlings, N.D. and Barrett, A.J . Intruduction: metallopeptidases and their clans. In: Handbook of Proteolytic Enzymes, Barrett, A.J., Rawlings, N.D. and Woessner, J.F. (eds), Elsevier Academic Press, London, 2004, pp. 231-268.
62. Rawlings, N.D., Morton, F.R. and Barrett, A.J. MEROPS: the peptidase database. Nucleic Acids Res. 2006. 34: D270-D272.
63. Relton, J.M., Gee, N.S., Matsas, R., Turner, A.J. and Kenny, A.J. Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography. Biochem. J. 1983. 215: 5195-23.
64. Roques, B.P., Fournié-Zaluski, M.-C., Soroca, E., Lecomte, J.-M., Malfroy, B., Llorens-Cortes, C. and Schwartz, J.-C. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature. 1980. 288: 286-288.
65. Ruchon, A.F., Marcinkiewicz, M., Ellefsen, K., Basak, A., Aubin, J., Crine, P., Boileau, G. Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides. J. Bone Miner Res. 2000. 15: 1266-1274.
66. Saito, T., Iwata, N., Tsubuki, S., Takaki, Y., Takano, J., Huang, S.M., Suemoto, T., Higuchi, M. and Saido, T.C. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat. Med. 2005. 11: 434-439.
67. Sales, N., Dutriez, I., Maziere, B., Ottaviani, M., Roques, B.P. Neutral endopeptidase 24.11 in rat peripheral tissues: comparative localization by 'ex vivo' and 'in vitro' autoradiography. Regul. Pept. 1991. 33: 209-222.
68. Skeggs, L.T., Kahn, J.R. and Shumway, N.P. J. The preparation and function of the hypertensin-converting enzyme. Exp. Med. 1956. 103: 295-299.
69. Snowdon, D.A., Greiner, L.H., Mortimer, J.A., Riley, K.P., Greiner, PA. and Markesbery, W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997. 277: 813-817.
70. Thomas, J.E., Rylett, C.M., Carhan, A., Bland, N.D., Bingham, R.J., Shirras, A.D., Turner, A.J. and Isaac, R.E. Drosophila melanogaster NEP2 is a new soluble member of the neprilysin family of endopeptidases with implications for reproduction and renal function. Biochem. J. 2005. 386: 357-366.
71. Thornton, E., Vink, R,. Blumbergs, P.C. and Van Den Heuvel, C. Soluble amyloid precursor protein α reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res. 2006. May 12; [Epub ahead of print].
72. Tikellis, C., Johnston, C.I., Forbes, J.M., Burns, W.C., Burrell, L.M., Risvanis, J. and Cooper, M.E. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension. 2004. 41: 392-397.
73. Tipnis, S.R., Hooper, N.M., Hyde, R., Karran, E., Christie, G. and Turner, A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000. 275: 33238-33243.
74. Towler, P., Staker, B., Prasad, S.G., Menon, S., Tang, J., Parsons, T., Ryan, D., Fisher, M., Williams, D., Dales, N.A., Patane, M.A. and Pantoliano, M.W.. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 2004. 279: 17996-18007.
75. Tran-Paterson, R., Willard, H.F. and Letarte, M. The common acute lymphoblastic leukemia antigen (neutral endopeptidase-3.4.24.11) gene is located on human chromosome 3. Cancer Genet. Cytogenet. 1989. 42: 129-134.
76. Turner, A.J. and Hooper, N.M. The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol. Sci. 2002. 23: 177-183.
77. Turner, A.J. and Tanzawa, K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 1997. 11: 355-364.
78. Turner, A.J., Fisk, L. and Nalivaeva, N. N. Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration. Ann. N. Y. Acad. Sci. 2004. 1035: 1-20.
79. Turner, A.J., Isaac, R.E. and Coates, D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays. 2001. 23: 261-269.
80. Turner, P.R., O'Connor, K., Tate, W.P. and Abraham, W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 2003. 70: 1-32.
81. Usmani, B.A., Harden, B., Maitland, N.J. and Turner, A.J. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines. Clin. Sci. (Lond). 2002. 103 (Suppl 48): 314S-317S.
82. Vassar, R. and Citron M. Aβ-generating enzymes: recent advances in β- and γ-secretase research. Neuron. 2000, 27: 419-422.
83. Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., Acton, S., Patane, M., Nichols, A. and Tummino, P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 2002. 277: 14838-14843.
84. Wen, Y., Onyewuchi, O., Yang, S., Liu, R., Simpkins, J.W. Increased β-secretase activity and expression in rats following transient cerebral ischemia. Brain Res. 2004. 1009: 1-8.
85. Wolfe, M.S., Xia, W., Ostaszewski, B.L., Diehl, T.S., Kimberly, W.T. and Selkoe, D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature. 1999. 398: 513-517.
86. Yasojima, K., Akiyama, H., McGeer, E.G. and McGeer, P.L. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide. Neurosci. Lett. 2001. 297: 97-100.
87. Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y.Q., Rogaeva, E., Chen, F., Kawarai, T., Supala, A., Levesque, L., Yu, H., Yang, D.S., Holmes, E., Milman, P., Liang, Y., Zhang, D.M., Xu, D.H., Sato, C., Rogaev, E., Smith, M., Janus, C., Zhang, Y., Aebersold, R., Farrer, L.S., Sorbi, S., Bruni, A., Fraser, P., St George-Hyslop, P. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature. 2000, 407: 48-54.
88. Zhang, H., Wada, J., Hida, K., Tsuchiyama, Y., Hiragushi, K., Shikata, K., Wang, H., Lin, S., Kanwar, Y.S. and Makino, H. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J. Biol. Chem. 2001. 276: 17132-17139.